The abstract is read at the publisher; the summary is JClub's.
HL-1B acts as a covalent molecular glue that stabilizes TOE1 binding to the spliceosome in a catalytically competent state, driving excess snRNA 3'-processing in human cells.
- Why it matters: Chemical tools to perturb snRNA structure and function are limited, and ncRNAs are often treated as undruggable, leaving a gap in ways to control RNA-processing interactomes in cells.
- What they did: Using chemical proteomics and cryo-electron microscopy, the study identifies HL-1B and tests how TOE1 and auxiliary regulators like SNRPB2 tune HL-1B–induced snRNA 3'-processing and splicing changes.
- The result: HL-1B–linked synthetic lethality correlates with preferential modulation of intermediate exon inclusion splicing events, and the work implicates snRNA tail length as a regulator of spliceosome function.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.